Omeros (OMER) Enterprise Value (2010 - 2026)
Omeros recorded quarterly Enterprise Value of -$135.3 million in Q1 2026, up 21.24% quarter-over-quarter from -$171.8 million in Q4 2025, and down 158.18% year-over-year from $232.6 million in Q1 2025.
Omeros' Enterprise Value history runs 17 years deep, the most recent figure standing at -$135.3 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 158.18% year-over-year to -$135.3 million; the TTM figure through Mar 2026 stood at -$135.3 million (down 158.18% YoY), while the FY2025 annual figure was -$171.8 million, down 90.61% from the prior year.
- Enterprise Value came in at -$135.3 million for Q1 2026 at Omeros, up from -$171.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$36.1 million in Q3 2025 to a low of -$458.8 million in Q1 2024.
- A 5-year average of -$214.4 million and a median of -$194.9 million in 2022 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value plunged 488.48% in 2022 and soared 88.58% in 2025, its largest moves.
- Omeros' Enterprise Value stood at -$194.9 million in 2022, then increased by 11.84% to -$171.8 million in 2023, then soared by 47.55% to -$90.1 million in 2024, then sank by 90.61% to -$171.8 million in 2025, then gained by 21.24% to -$135.3 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$135.3 million, -$171.8 million, and -$36.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | -135.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -135.32 Mn |
| Dec 31, 2025 | -171.80 Mn |
| Sep 30, 2025 | -36.09 Mn |
| Jun 30, 2025 | -55.54 Mn |
| Mar 31, 2025 | -52.41 Mn |
| Dec 31, 2024 | -90.13 Mn |
| Sep 30, 2024 | -244.84 Mn |
| Jun 30, 2024 | -315.69 Mn |
| Mar 31, 2024 | -458.80 Mn |
| Dec 31, 2023 | -171.85 Mn |
| Sep 30, 2023 | -310.31 Mn |
| Jun 30, 2023 | -341.28 Mn |
| Mar 31, 2023 | -371.33 Mn |
| Dec 31, 2022 | -194.92 Mn |
| Sep 30, 2022 | -296.43 Mn |
| Jun 30, 2022 | -122.53 Mn |
| Mar 31, 2022 | -275.47 Mn |
| Dec 31, 2021 | -157.27 Mn |
| Sep 30, 2021 | -50.37 Mn |
| Jun 30, 2021 | -73.66 Mn |
| Mar 31, 2021 | -100.46 Mn |
| Dec 31, 2020 | -134.95 Mn |
| Sep 30, 2020 | -153.52 Mn |
| Jun 30, 2020 | -16.12 Mn |
| Mar 31, 2020 | -53.96 Mn |
| Dec 31, 2019 | -60.80 Mn |
| Sep 30, 2019 | -27.38 Mn |
| Jun 30, 2019 | -31.86 Mn |
| Mar 31, 2019 | -47.22 Mn |
| Dec 31, 2018 | -60.54 Mn |
| Sep 30, 2018 | -55.16 Mn |
| Jun 30, 2018 | -88.40 Mn |
| Mar 31, 2018 | -72.81 Mn |
| Dec 31, 2017 | -83.75 Mn |
| Sep 30, 2017 | -86.81 Mn |
| Jun 30, 2017 | -29.67 Mn |
| Mar 31, 2017 | -33.65 Mn |
| Dec 31, 2016 | -45.33 Mn |
| Sep 30, 2016 | -47.44 Mn |
| Jun 30, 2016 | -21.24 Mn |
| Mar 31, 2016 | -13.24 Mn |
| Dec 31, 2015 | -28.26 Mn |
| Sep 30, 2015 | -35.00 Mn |
| Jun 30, 2015 | -51.45 Mn |
| Mar 31, 2015 | -70.06 Mn |
| Dec 31, 2014 | -6.89 Mn |
| Sep 30, 2014 | -21.78 Mn |
| Jun 30, 2014 | -37.46 Mn |
| Mar 31, 2014 | -52.19 Mn |
| Dec 31, 2013 | -14.10 Mn |
| Sep 30, 2013 | -9.00 Mn |
| Jun 30, 2013 | -20.06 Mn |
| Mar 31, 2013 | -13.75 Mn |
| Dec 31, 2012 | -22.35 Mn |
| Sep 30, 2012 | -30.63 Mn |
| Jun 30, 2012 | -7.27 Mn |
| Mar 31, 2012 | -17.62 Mn |
| Dec 31, 2011 | -24.57 Mn |
| Sep 30, 2011 | -32.85 Mn |
| Jun 30, 2011 | -36.87 Mn |
| Mar 31, 2011 | -3.92 Mn |
| Dec 31, 2010 | -41.99 Mn |
| Sep 30, 2010 | -2.80 Mn |
| Jun 30, 2010 | -2.87 Mn |